Comparison of methods used for evaluation of mutagenicity/genotoxicity of model chemicals - parabens

. 2020 Dec 31 ; 69 (Suppl 4) : S661-S679.

Jazyk angličtina Země Česko Médium print

Typ dokumentu srovnávací studie, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid33646007

Growing worldwide efforts to replace (reduce) animal testing and to improve alternative in vitro tests which may be more efficient in terms of both time, cost and scientific validity include also genotoxicity/mutagenicity endpoints. The aim of the review article was to summarize currently available in vitro testing approaches in this field, their regulatory acceptance and recommended combinations for classification of chemicals. A study using the combination of Comet Assay performed on two cell lines and the Chromosomal Aberration test on human peripheral lymphocytes was performed with the aim to predict the genotoxic potential of selected paraben esters, serving as a model chemical group. Parabens are widely used in consumer products as preservatives and have been reported to exhibit inconclusive results in numerous genotoxicity studies. The Comet Assay identified Ethylparaben and Benzylparaben as potentially genotoxic. The Chromosomal Aberration test revealed weak genotoxic potential in case of Ethylparaben and positive genotoxicity in case of Butylparaben, Propylparaben and Isopropylparaben. The main reasons for variability seem to be limited water solubility of parabens, determining their bioavailability at the cellular level, and absence of metabolic activation in the Comet Assay. The results confirmed that the Comet Assay should serve as a screening test and should not be used as a stand-alone method for classification of genotoxicity. The weight of evidence approach in risk assessment should be supported with data generated with the use of human relevant in vitro methods based on cells / tissues of human origin.

Zobrazit více v PubMed

ALÉPÉE N, BAHINSKI A, DANESHIAN M, De WEVER B, FRITSCHE E, GOLDBERG A, HANSMANN J, HARTUNG T, HAYCOCK J, HOGBERG H, HOELTING L, KELM JM, KADEREIT S, McVEY E, LANDSIEDEL R, LEIST M, LÜBBERSTEDT M, NOOR F, PELLEVOISIN C, PETERSOHN D, PFANNENBECKER U, REISINGER K, RAMIREZ T, ROTHEN-RUTISHAUSER B, SCHÄFER-KORTING M, ZEILINGER K, ZURICH MG. t4 workshop report: State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX. 2014;31:441–477. doi: 10.14573/altex1406111. PubMed DOI PMC

ALLEMANG A, MAHONY C, LESTER C, PFUHLER S. Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells. Food Chem Toxicol. 2018;121:72–81. doi: 10.1016/j.fct.2018.08.003. PubMed DOI

ANDERSEN ME, BETTS K, DRAGAN Y, FITZPATRICK S, GOODMAN JL, HARTUNG T, HIMMELFARB J, INGBER DE, JACOBS A, KAVLOCK R, KOLAJA K, STEVENS JL, TAGLE D, LANSING TAYLOR D, THROCKMORTON D. Developing microphysiological systems for use as regulatory tools - challenges and opportunities. ALTEX. 2014;31:64–367. doi: 10.14573/altex.1405151. PubMed DOI PMC

BARR L, METAXAS G, HARBACH CA, SAVOY LA, DARBRE PD. Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol. 2012;32:219–232. doi: 10.1002/jat.1786. PubMed DOI

BEKEN S, KASPER P, Van der LAAN JW. Regulatory acceptance of alternative methods in the development and approval of pharmaceuticals. Adv Exp Med Biol. 2016;856:3–64. doi: 10.1007/978-3-319-33826-2_3. PubMed DOI

BENIGNI R, BOSSA C, TCHEREMENSKAIA O, BATTISTELLI CL, CRETTAZ P. The new ISSMIC database on in vivo micronucleus and its role in assessing genotoxicity testing strategies. Mutagenesis. 2012;27:87–92. doi: 10.1093/mutage/ger064. PubMed DOI

BHAGAT J. Combinations of genotoxic tests for the evaluation of group 1 IARC carcinogens. J Appl Toxicol. 2018;38:81–99. doi: 10.1002/jat.3496. PubMed DOI

BILAL M, IQBAL HMN. An insight into toxicity and human-health-related adverse consequences of cosmeceuticals - A review. Sci Total Environ. 2019;670:555–568. doi: 10.1016/j.scitotenv.2019.03.261. PubMed DOI

BORTOLUZZI MC, CAMPAGNOLI EB, MILAN JR, REINHEIMER A, MASSON M, CAPELLA DL. Frequency of micronucleus in oral epithelial cells after exposure to mate-tea in healthy humans. Med Oral Patol Oral Cir Bucal. 2014;19:45–349. doi: 10.4317/medoral.19570. PubMed DOI PMC

BOWEN D, WHITWELL JH, LILLFORD L, HENDERSON D, KIDD D, McGARRY S, PEARCE G, BEEVERS C, KIRKLAND DJ. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res. 2011;722:7–19. doi: 10.1016/j.mrgentox.2011.02.009. PubMed DOI

CERVENA T, ROSSNEROVA A, SIKOROVA J, BERANEK V, VOJTISEK-LOM M, CIGANEK M, TOPINKA J, ROSSNER P. DNA damage potential of engine emissions measured in vitro by micronucleus test in human bronchial epithelial cells. Basic Clin Pharmacol Toxicol. 2017;121:102–108. doi: 10.1111/bcpt.12693. PubMed DOI

CHAMANZA R, WRIGHT JA. A review of the comparative anatomy, histology, physiology and pathology of the nasal cavity of rats, mice, dogs and non-human primates. Relevance to inhalation toxicology and human health risk assessment. J Comp Pathol. 2015;153:287–314. doi: 10.1016/j.jcpa.2015.08.009. PubMed DOI

CHAUNG W, MI L-J, BOORSTEIN RJ. The p53 status of Chinese hamster V79 cells frequently used for studies of DNA damage and DNA repair. Nucleic Acid Res. 1997;25:992–994. doi: 10.1093/nar/25.5.992. PubMed DOI PMC

CHARNOCK C, FINSRUD T. Combining esters of para-hydroxy benzoic acid (parabens) to achieve increased antimicrobial activity. J Clin Pharm Ther. 2007;32:567–572. doi: 10.1111/j.1365-2710.2007.00854.x. PubMed DOI

CIOMS. International Ethical Guidelines for Health-related Research Involving Humans. 2016. https://cioms.ch/wp-content/uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf . PubMed

COLEMAN K, DAI X, DENG X, LAKEHAL F, TANG X. Medical device biocompatibility evaluation: An industry perspective. In: Boutrand J, editor. Biocompatibility and Performance of Medical Devices. Cambridge, UK: Woodhead Publishing Ltd; 2012. DOI

COM. Guidance on a Strategy for genotoxicity Testing and mutagenic hazard assessment of Chemical substances. Committee on Mutagenicity of Chemicals in Food, Consumer Products And the Environment (COM); 2011. http://www.iacom.org.uk/publications/documents/StrategyGuidanceCOMconsultation3.pdf .

COMBES RD, BALLS M. The Three Rs-opportunities for improving animal welfare and the quality of scientific research. Altern Lab Anim. 2014;42:245–259. doi: 10.1177/026119291404200406. PubMed DOI

CORVI R, ALBERTINI S, HARTUNG T, HOFFMAN S, MAURICI D, PFUHLER S, BENTHEM J, VANPARYS P. ECVAM retrospective validation of in vitro micronucleus test (MNT) Mutagenesis. 2008;23:271–283. doi: 10.1093/mutage/gen010. PubMed DOI PMC

COX JA, FELLOWS MD, HASHIZUME T, WHITE PA. The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment. Mutagenesis. 2016;31:117–130. doi: 10.1093/mutage/gev082. PubMed DOI

CRETON S, DEWHURST IC, EARL LK, GEHEN SC, GUEST RL, HOTCHKISS JA, INDANS I, WOOLHISER MR, BILLINGTON R. Acute toxicity testing of chemicals-opportunities to avoid redundant testing and use alternative approaches. Crit Rev Toxicol. 2010;40:50–83. doi: 10.3109/10408440903401511. PubMed DOI

DAL NEGRO G, VANDIN L, BONATO M, SCIUSCIO D. Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system. Toxicol in vitro. 2006;20:743–749. doi: 10.1016/j.tiv.2005.10.016. PubMed DOI

DARBRE PD, ALJARRAH A, MILLER WR, COLDHAM NG, SAUER MJ, POPE GS. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004;24:5–13. doi: 10.1002/jat.958. PubMed DOI

DARBRE PD, HARVEY PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008;28:561–578. doi: 10.1002/jat.1358. PubMed DOI

DEARFIELD KL, THYBAUD V, CIMINO MC, CUSTER L, CZICH A, HARVEY JS, HESTER S, KIM JH, KIRKLAND D, LEVY DD, LORGE E, MOORE MM, OUÉDRAOGO-ARRAS G, SCHULER M, SUTER W, SWEDER K, TARLO K, VAN BENTHEM J, VAN GOETHEM F, WITT KL. Follow-up actions from positive results of in vitro genetic toxicity testing. Environ Mol Mutagen. 2011;52:177–204. doi: 10.1002/em.20617. PubMed DOI

De BOECK M, Van der LEEDE B, Van GOETHEM F, De SMEDT A, STEEMANS M, AL, VANPARYS P. Flow cytometric analysis of micronucleated reticulocytes: Time- and dose dependent response of known mutagens in mice, using multiple blood sampling. Environ Molec Mutagen. 2005;46:0–42. doi: 10.1002/em.20127. PubMed DOI

DERTINGER SD, TOROUS DK, HAYASHI M, MacGREGOR JT. Flow cytometric scoring of micronucleated erythrocytes: an efficient platform for assessing in vivo cytogenetic damage. Mutagenesis. 2011;26:139–145. doi: 10.1093/mutage/geq055. PubMed DOI

Directive 2010/63/EU of the European Parliament and the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official J EU. 2010;276:33–79.

EC. COUNCIL REGULATION (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) 2008

EC. COUNCIL REGULATION (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) Official Journal L. 2009;2009;342:59.

ECHA. Report on Non-animal approaches - Current status of regulatory applicability under the REACH, CLP and Biocidal Products regulations. 2017. https://echa.europa.eu/documents/10162/22931011/non_animal_approcches_en.pdf/87ebb68f-2038-f597-fc33-f4003e9e7d7d .

ECVAM. DB-ALM Protocol No 46. BALB/c 3T3 Neutral Red Uptake (NRU) Cytotoxicity Test. 1992. http://cidportal.jrc.ec.europa.eu/ftp/jrc-opendata/EURLECVAM/datasets/DBALM/LATEST/online/DBALM_docs/46_P_BALBc%203T3%20Neutral%20Red%20Uptake%20(NRU)%20Cytotoxicity%20Test.pdf .

EFSA 2011 (European Food Safety Authority) Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA Journal. 2011;2379:1–68.

EFSA. Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. 2012. https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2011.2379. https://doi.org/10.2903/j.efsa.2011.2379. DOI

EFSA. Statement on Genotoxicity assessment of chemical mixtures. 2018. https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2019.5519 https://doi.org/10.2903/j.efsa.2019.5519. PubMed DOI PMC

FLÜCKIGER-ISLER S, BAUMEISTER M, BRAUN K, GERVAIS V, HASLER-NGUYEN N, REIMANN R, VAN GOMPEL J, WUNDERLICH HG, ENGELHARDT G. Assessment of the performance of the Ames II assay: a collaborative study with 19 coded compounds. Mutat Res. 2004;558:181–197. doi: 10.1016/j.mrgentox.2003.12.001. PubMed DOI

FOWLER P, SMITH K, YOUNG J, JEFFREY L, KIRKLAND D, PFUHLER S, CARMICHAEL P. Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutat Res. 2012;742:11–25. doi: 10.1016/j.mrgentox.2011.10.014. PubMed DOI

FRANSWAY AF, FRANSWAY PJ, BELSITO DV, YIANNIAS JA. Paraben Toxicology. Dermatitis. 2019;30:2–45. doi: 10.1097/DER.0000000000000428. PubMed DOI

GIANNOTTI E, VANDIN L, REPETO P, COMELLI R. A comparison of the in vitro Comet assay with the in vitro chromosome aberration assay using whole human blood or Chinese hamster lung cells: validation study using a range of novel pharmaceuticals. Mutagenesis. 2002;17:163–170. doi: 10.1093/mutage/17.2.163. PubMed DOI

GIORDANO F, BETTINI R, DONINI C, GAZZANIGA A, CAIRA MR, ZHANG GG, GRANT DJ. Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures. J Pharm Sci. 1999;88:1210–1216. doi: 10.1021/js9900452. PubMed DOI

GÜZEL BAYÜLKEN D, AYAZ TÜYLÜ B, SINAN H, SIVAS H. Investigation of genotoxic effects of paraben in cultured human lymphocytes. Drug Chem Toxicol. 2019;42:49–356. doi: 10.1080/01480545.2017.1414834. PubMed DOI

GÜZEL BAYÜLKEN D, AYAZ TÜYLÜ B. In vitro genotoxic and cytotoxic effects of some paraben esters on human peripheral lymphocytes. Drug Chem Toxicol. 2019;42:86–393. doi: 10.1080/01480545.2018.1457049. PubMed DOI

HE X, TOTH TL. In vitro culture of ovarian follicles from Peromyscus. Semin Cell Dev Biol. 2017;61:140–149. doi: 10.1016/j.semcdb.2016.07.006. PubMed DOI PMC

HONG YH, JEON HL, KO KY, KIM J, YI JS, AHN I, KIM TS, LEE JK. Assessment of the predictive capacity of the optimized in vitro comet assay using HepG2 cells. Mutat Res. 2018;827:59–67. doi: 10.1016/j.mrgentox.2018.01.010. PubMed DOI

JIRAVOVA J, TOMANKOVA KB, HARVANOVA M, MALINA L, MALOHLAVA J, LUHOVA L, PANACEL A, MANISOVA B, KOLAROVA H. The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro. Food Chem Toxicol. 2016;96:50–61. doi: 10.1016/j.fct.2016.07.015. PubMed DOI

JOSSÉ R, ROGUE A, LORGE E, GUILLOUZO A. An adaptation of the human HepaRG cells to the in vitro micronucleus assay. Mutagenesis. 2012;27:295–304. doi: 10.1093/mutage/ger076. PubMed DOI

JYOTI S, KHAN S, AFZAL M, SIDDIQUE YH. Micronucleus investigation in human buccal epithelial cells of gutkha users. Adv Biomed Res. 2012;1:35. doi: 10.4103/2277-9175.100128. PubMed DOI PMC

JYOTI S, SIDDIQUE YH, KHAN S, NAZ F, RAHUL, ALI F. Effect on micronucleus frequency and DNA damage in buccal epithelial cells of various factors among pan masala and gutkha chewers. Oral Science International. 2015;12:9–14. doi: 10.1016/S1348-8643(14)00030-5. DOI

KANG SH, KWON JY, LEE JK, SEO YR. Recent advances in in vivo genotoxicity testing: Prediction of carcinogenic potential using comet and micronucleus assay in animal models. J Cancer Prev. 2013a;18:277–288. doi: 10.15430/JCP.2013.18.4.277. PubMed DOI PMC

KANG S, KIM S, PARK J, KIM HJ, LEE J, CHOI G, CHOI S, KIM S, KIM SY, MOON HB, KIM S, KHO YL, CHOI K. Urinary paraben concentrations among pregnant women and their matching newborn infants of Korea, and the association with oxidative stress biomarkers. Sci Total Environ. 2013b;461–462:214–221. doi: 10.1016/j.scitotenv.2013.04.097. PubMed DOI

KAPALAVAVI B, ANKNEY J, BAUCOM M, YANG Y. Solubility of parabens in subcritical water. J Chem Eng. 2014;59:912–916. doi: 10.1021/je4010883. DOI

KAWAGUCHI S, NAKAMURA T, YAMAMOTO A, HONDA G, SASAKI YF. Is the comet assay a sensitive procedure for detecting genotoxicity? J Nucleic Acids. 2010:541050. doi: 10.4061/2010/541050. PubMed DOI PMC

KERECMAN MD, GOLDBERG AM, POTH A, WOLF MF, CARRAWAY J, McKIM J, COLEMAN KP, HUTCHINSON R, BROWN R, KRUG HF, BAHINSKI A, HARTUNG T. From in vivo to in vitro: The medical device testing paradigm shift. ALTEX. 2017;34:479–500. doi: 10.14573/altex.1608081. PubMed DOI

KIM BS, MARGOLIN BH. Prediction of rodent carcinogenicity utilizing a battery of in vitro and In vivo genotoxicity tests. Environ Mol Mutagen. 1999;34:297–304. doi: 10.1002/(SICI)1098-2280(1999)34:4<297::AID-EM11>3.0.CO;2-Z. PubMed DOI

KIM MJ, KIM CH, AN MJ, LEE JH, SHIN GS, SONG M, KIM JW. Ethylparaben induces apoptotic cell death in human placenta BeWo cells via the Caspase-3 pathway. Anim Cells Syst. 2020;24:4–43. doi: 10.1080/19768354.2020.1711804. PubMed DOI PMC

KIMURA A, MIYATA A, HONMA M. A combination of in vitro comet assay and micronucleus test using human lymphoblastoid TK6 cells. Mutagenesis. 2013;28:583–590. doi: 10.1093/mutage/get036. PubMed DOI

KIRKLAND DJ, AARDEMA M, HENDERSON L, MÜLLER L. Evaluation of the ability of a battery of 3 In vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat Res. 2005;584:1–256. doi: 10.1016/j.mrgentox.2005.02.004. PubMed DOI

KIRKLAND DJ, PFUHLER S, TWEATS D, AARDEMA M, CORVI R, DARROUDI F, ELHAJOUJI A, GLATT H, HASTWELL P, HAYASHI M, KASPER P, KIRCHNER S, LYNCH A, MARZIN D, MAURICI D, MEUNIER JR, MÜLLER L, NOHYNEK G, PARRY J, PARRY E, THYBAUD V, TICE R, Van BENTHEM J, VANPARYS P, WHITE P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutat Res. 2007;628:1–55. doi: 10.1016/j.mrgentox.2006.11.008. PubMed DOI

KIRKLAND DJ, REEVE L, GATEHOUSE D, VANPARYS P. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res. 2011;721:27–73. doi: 10.1016/j.mrgentox.2010.12.015. PubMed DOI

KIRSCH-VOLDERS M, DECORDIER I, ELHAJOUJI A, PLAS G, AARDEMA MJ, FENECH M. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis. 2011;26:177–184. doi: 10.1093/mutage/geq068. PubMed DOI

MADRIGAL-BUJAIDAR E, MADRIGAL-SANTILLAN E, ALVAREZ-GONZALEZ I, BAEZ R, MARQUEZ P. Micronuclei induced by imipramine and desipramine in mice: a subchronic study. Bas Clinic Pharmacol Toxicol. 2008;103:569–573. doi: 10.1111/j.1742-7843.2008.00328.x. PubMed DOI

MARX U, ANDERSSON TB, BAHINSKI A, BEILMANN M, BEKEN S, CASSEE FR, CIRIT M, DANESHIAN M, FITZPATRICK S, FREY O, GAERTNER C, GIESE C, GRIFFITH L, HARTUNG T, HERINGA MB, HOENG J, DE JONG WH, KOJIMA H, KUEHNL J, LEIST M, LUCH A, MASCHMEYER I, SAKHAROV D, SIPS AJ, STEGER-HARTMANN T, TAGLE DA, TONEVITSKY A, TRALAU T, TSYB S, Van de STOLPE A, VANDEBRIEL R, VULTO P, WANG J, WIEST J, RODENBURG M, ROTH A. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX. 2016;33:272–321. doi: 10.14573/altex.1603161. PubMed DOI PMC

McCARRICK S, CUNHA V, ZAPLETAL O, VONDRÁČEK J, DREIJ K. In vitro and in vivo genotoxicity of oxygenated polycyclic aromatic hydrocarbons. Environ Pollut. 2019;246:678–687. doi: 10.1016/j.envpol.2018.12.092. PubMed DOI

MORITA T, ASANO N, AWOGI T, SASAKI YF, SATO S, SHIMADA H, WAKATA A, SOFUNI T, HAYASHI M. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B): The summary report of the 6th collaborative study by CSGMT/JEMS·MMS. Mutat Res. 1997;389:3–122. doi: 10.1016/S1383-5718(96)00070-8. PubMed DOI

MORITA T, HAMADA S, MASUMURA K, WAKATA A, MANIWA J, TAKASAWA H, HONMA M. Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens. Mutat Res. 2016;802:1–29. doi: 10.1016/j.mrgentox.2016.03.008. PubMed DOI

MOSMANN T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. PubMed DOI

MOWAT V, ALEXANDER DJ, PILLING AM. A comparison of rodent and nonrodent laryngeal and tracheal bifurcation sensitivities in inhalation toxicity studies and their relevance for human exposure. Toxicol Pathol. 2017;45:216–222. doi: 10.1177/0192623316678695. PubMed DOI

NESSLANY F. The current limitations of in vitro genotoxicity testing and their relevance to the in vivo situation. Food Chem Toxicol. 2017;106(Pt B):609–615. doi: 10.1016/j.fct.2016.08.035. PubMed DOI

NISHIMUTA H, NAKAGAWA T, NOMURA N, YABUKI M. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs. Xenobiotica. 2013;43:948–955. doi: 10.3109/00498254.2013.787155. PubMed DOI

NORPPA H, BONASSI S, HANSTEEN I-L, HAGMAR L, STRÖMBERG U, RÖSSNER P, LAZUTKA J. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res. 2006;600:7–45. doi: 10.1016/j.mrfmmm.2006.05.030. PubMed DOI

OECD. OECD Guideline for testing of chemicals - Guideline 471: Bacterial Reverse Mutation Test. Organization for Economic Cooperation and Development; Paris: 1997. adopted 26 May 1983, last updated 21 July 1997. https://www.oecd.org/general/searchresults/?q=oecd%20471&cx=012432601748511391518:xzeadub0b0a&cof=FORID:11&ie=UTF-8.

OECD. Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines. 2015. Aug 31, 2015. https://www.oecd.org/chemicalsafety/testing/Genetic%20Toxicology%20Guidance%20Document%20Aug%2031%202015.pdf .

OECD. OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing; Paris: 2016a. Test No. 473: In vitro Mammalian Chromosomal Aberration Test. DOI

OECD. Test No. 476: In vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing; Paris: 2016b. DOI

OECD. Test No. 487: In vitro Mammalian Cell Micronucleus Test, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing; Paris: 2016c. DOI

OECD. Test No. 489: In vivo Mammalian Alkaline Comet Assay, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing; Paris: 2016d. DOI

OECD. Test No. 490: In vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing; Paris: 2016e. DOI

OECD. Overview on genetic toxicology TGs. OECD Publishing; Paris: 2017. (OECD Series on Testing and Assessment, No. 238). DOI

OESCH F, FABIAN E, LANDSIEDEL R. Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models. Arch Toxicol. 2019;93:419–3489. doi: 10.1007/s00204-019-02602-7. PubMed DOI

PARTON JW, HOFFMAN WP, GARRIOTT ML. Validation of an automated image analysis micronucleus scoring system. Mutat Res. 1996;370:65–73. doi: 10.1016/S0165-1218(96)90128-7. PubMed DOI

PERLOVICH GL, RODIONOV SV, BAUER-BRANDL A. Thermodynamics of solubility, sublimation and solvation processes of parabens. Eur J Pharm Sci. 2005;24(1):25–33. doi: 10.1016/j.ejps.2004.09.007. PubMed DOI

PFUHLER S, KIRKLAND D, HAYASHI M, VANPARYS P, CARMICHAEL P, DERTINGER S, EASTMOND D, ELHAJOUJI A, KRUL C, ROTHFUSS A, SCHOENING G, SMITH A, SPEIT G, THOMAS C, Van BENTHEM J, CORVI R. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities - Report from an ECVAM workshop. Mutat Res. 2009;680:1–42. doi: 10.1016/j.mrgentox.2009.09.002. PubMed DOI

PFUHLER S, PIROW R, DOWNS TR, HAASE A, HEWITT N, LUCH A, MERKEL M, PETRICK C, SAID A, SCHÄFER-KORTING M, REISINGER K. Validation of the 3D reconstructed human skin Comet assay, an animal-free alternative for following-up positive results from standard in vitro genotoxicity assays. Mutagenesis. 2020a;20:1–17. doi: 10.1093/mutage/geaa009. PubMed DOI PMC

PFUHLER S, Van BENTHEM J, CURREN R, DOAK SH, DUSINSKA M, HAYASHI M, HEFLICH RH, KIDD D, KIRKLAND D, LUAN Y, OUEDRAOGO G, REISINGER K, SOFUNI T, Van ACKER F, YANG Y, CORVI R. Use of in vitro 3D tissue models in genotoxicity testing: Strategic fit, validation status and way forward. Report of the working group from the 7th International Workshop on Genotoxicity Testing (IWGT) Mutat Res. 2020b;1:850–851. doi: 10.1016/j.mrgentox.2020.503135. PubMed DOI

PHALEN RF, OLDHAM MJ, WOLFF RK. The relevance of animal models for aerosol studies. J Aerosol Med Pulm Drug Deliv. 2008;21:113–124. doi: 10.1089/jamp.2007.0673. PubMed DOI

PUERTO M, PRIETO AI, MAISANABA S, GUTIÉRREZ-PRAENA D, MELLADO-GARCÍ Cylindrospermopsin by a battery of in vitro tests. Food Chem Toxicol. 2018;121:413–422. doi: 10.1016/j.fct.2018.09.013. PubMed DOI

RANGANATHA R, CHAKRAVARTHY S, SUKUMARAN SK. High-throughput approaches for genotoxicity testing in drug development: recent advances. J High Trough Sreen. 2016;6:1–12. doi: 10.2147/IJHTS.S70362. DOI

RECIO L, HOBBS C, CASPARY W, WITT KL. Dose-response assessment of four genotoxic chemicals in a combined mouse and rat micronucleus and comet assay protocol. J Toxicol Sci. 2010;35:149. doi: 10.2131/jts.35.149. PubMed DOI PMC

REISINGER K, BLATZ V, BRINKMANN J, DOWNS T, FISCHER A, HENKLER F, HOFFMANN S, KRUL C, LIEBSCH M, LUCH A, PIROW R, REUS A, SCHULZ M, PFUHLER S. Validation of the 3D Skin Comet assay using full thickness skin models: Transferability and reproducibility. Mutat Res Genet Toxicol Environ Mutagen. 2018;827:27–41. doi: 10.1016/j.mrgentox.2018.01.003. PubMed DOI

ROSSINI GP, HARTUNG T. Towards tailored assays for cell-based approaches to toxicity testing. ALTEX. 2012;29:59–372. doi: 10.14573/altex.2012.4.359. PubMed DOI

ROSZAK J, DOMERADZKA-GAJDA K, SMOK-PIENIĄŻEK A, KOZAJDA A, SPRYSZYŃSKA S, GROBELNY J, STĘPNIK M. Genotoxic effects in transformed and nontransformed human breast cell lines after exposure to silver nanoparticles in combination with aluminium chloride, butylparaben or di-n-butylphthalate. Toxicol In vitro. 2017;45:181–193. doi: 10.1016/j.tiv.2017.09.003. PubMed DOI

ROY S, KULKARNI R, HEWITT NJ, AARDEMA MJ. The EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay: Historical control data and proof of principle studies for mechanistic assay adaptations. Mutat Res. 2016;805:25–37. doi: 10.1016/j.mrgentox.2016.05.010. PubMed DOI

RUSSELL WMS, BURCH RL. The Principles of Humane Experimental Technique. UK: Methuen, London; 1959. p. 238.

SCCP 2011 Scientific Committee on Consumer Products (SCCP) Opinion on parabens, COLIPA No P82. European Commission; Directorate-General for Health & Consumers; 2011. [Date Accessed 2-13-2012]. pp. 1–36. Report No. SCCS/1348/10. https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_041.pdf .

SCCP 2013 Scientific Committee on Consumer Products (SCCP) Opinion on parabens; Updated request for a scientific opinion on propyl and butylparaben, COLIPA No P82. European Commission; 2013. Report No. SCCS/1514/13. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_132.pdf.

SCF. Reports of the Scientific Committee for Food, Thirty-Fifth Series. CEC; Luxembourg: 1994. 1994. Opinion on benzoic acid and its salts. Expressed on 24 February 1994; pp. 33–39.

SHELBY M, ZEIGER E. Series: ‘current issues in mutagenesis and carcinogenesis’ no. 20 activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat Res. 1990;234:257–261. doi: 10.1016/0165-1161(90)90022-G. PubMed DOI

SOETEMAN-HERNÁNDEZ LG, JOHNSON GE, SLOB W. Estimating the carcinogenic potency of chemicals from the in vivo micronucleus test. Mutagenesis. 2016;31:47–358. doi: 10.1093/mutage/gev043. PubMed DOI PMC

SONI MG, BURDOCK GA, TAYLOR SL, GREENBERG NA. Safety assessment of propyl paraben: a review of the published literature. Food Chem Toxicol. 2001;39:513–532. doi: 10.1016/S0278-6915(00)00162-9. PubMed DOI

SONI MG, CARABIN IG, BURDOCK GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens) Food Chem Toxicol. 2005;43:985–1015. doi: 10.1016/j.fct.2005.01.020. PubMed DOI

STOLTZ D, POIRIER L, IRVING C, STICH H, WEISBURGER J, GRICE H. Evaluation of short-term tests for carcinogenicity. Toxicol Appl Pharmacol. 1974;29:157–180. doi: 10.1016/0041-008X(74)90054-4. PubMed DOI

STORER RD, KRAYNAK AR, McKELVEY TW, ELIA MC, GOODROW TL, DELUCA JG. The mouse lymphoma L5178Y Tk+/− cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res. 1997;373:157–165. doi: 10.1016/S0027-5107(96)00227-8. PubMed DOI

STYLES JA, CLARK H, FESTING MF, REW DA. Automation of mouse micronucleus genotoxicity assay by laser scanning cytometry. Cytometry. 2001;44:153–155. doi: 10.1002/1097-0320(20010601)44:2<153::AID-CYTO1095>3.0.CO;2-H. PubMed DOI

TAYAMA S, NAKAGAWA Y, TAYAMA K. Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. Mutat Res. 2008;649:114–125. PubMed

TICE RR, AGURELL E, ANDERSON D, BURLINSON B, HARTMANN A, KOBAYASHI H, MIYAMAE Y, ROJAS E, RYU JC, SASAKI YF. Single cell gel/comet assay: guidelines for in vitro and In vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35:206–221. doi: 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J. PubMed DOI

TURKEZ H, ARSLAN ME, OZDEMIR O. Genotoxicity testing: progress and prospects for the next decade. Expert Opin Drug Metab Toxicol. 2017;13:1089–1098. doi: 10.1080/17425255.2017.1375097. PubMed DOI

TWEATS DJ, BLAKEY D, HEFLICH RH, JACOBS A, JACOBSEN SD, MORITA T, NOHMI T, O’DONOVAN MR, SASAKI YF, SOFUNI T, TICE R. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutat Res. 2007a;627:92–105. doi: 10.1016/j.mrgentox.2006.10.006. PubMed DOI PMC

TWEATS DJ, SCOTT AD, WESTMORELAND C, CARMICHAEL PL. Determination of genetic toxicity and potential carcinogenicity in vitro-challenges post the Seventh Amendment to the European Cosmetics Directive. Mutagenesis. 2007b;22:5–13. doi: 10.1093/mutage/gel052. PubMed DOI

VASQUEZ MZ. Combining the in vivo comet and micronucleus assays: A practical approach to genotoxicity testing and data interpretation. Mutagenesis. 2010;25:187–199. doi: 10.1093/mutage/gep060. PubMed DOI PMC

WIECZERZAK M, NAMIEŚNIK J, KUDŁAK B. Genotoxicity of selected pharmaceuticals, their binary mixtures, and varying environmental conditions - study with human adenocarcinoma cancer HT29 cell line. Drug Chem Toxicol. 2019;4:1–11. doi: 10.1080/01480545.2018.1529783. PubMed DOI

WMA. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 1964. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects . PubMed

WU Y, WANG G. Machine learning based toxicity prediction: from chemical structural description to transcriptome analysis. Int J Mol Sci. 2018;19:2358. doi: 10.3390/ijms19082358. PubMed DOI PMC

XU J, MA M, PURCELL WM. Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: II. nitric oxide synthesis and related changes. J Cell Biochem. 2003;90:1176–1185. doi: 10.1002/jcb.10731. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...